CastleKnight Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-46,371
Closed -$454K 286
2022
Q1
$454K Buy
+46,371
New +$19.9K 0.06% 183

Other funds holding TLSIW

CastleKnight Management's TLSIW Position: Q3 2024 in Review

CastleKnight Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2024, closing a stake of 46,371 shares — an estimated $84.4K sold.

CastleKnight Management first reported a position in TLSIW in Q4 2021 and held it in 10 quarters. The position peaked at $84.4K in Q2 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q3 2024.

  • CastleKnight Management reported no remaining TriSalus Life Sciences Warrant position as of Q3 2024 after selling out during the quarter.
  • CastleKnight Management sold 46,371 TriSalus Life Sciences Warrant shares in Q3 2024, an estimated $84.4K.
  • CastleKnight Management first reported a position in TriSalus Life Sciences Warrant in Q4 2021 and held it in 10 quarters.
  • CastleKnight Management's TriSalus Life Sciences Warrant position peaked at $84.4K in Q2 2024.
  • 8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2024.

Based on CastleKnight Management's 13F filing for Q3 2024, filed 14 Nov 2024.